ABSTRACT
Objectives This study was carried out to determine the knowledge, practice and barriers regarding the use of Tranexamic acid for the prevention and treatment of postpartum hemorrhage among health care providers in Enugu, Nigeria.
Methods A cross sectional study was carried out among health professionals (Doctors, Pharmacists and Nurses) in two Nigerian tertiary teaching hospitals. One is Federal and the other is State. A total of 220 questionnaires were distributed, 207 were collected back (response rate: 94%) and analyzed using SPSS for inferential statistics with level of significance at p < 0.05.
Results Only 23.7% of the respondents had good Knowledge (p<0.001). Good awareness of the recent WHO recommendation on the use of Tranexamic acid for Postpartum Haemorrhage was low (19.8%, <0.001). Majority of the respondents have neither prescribed nor dispensed it (30%; <0.001). Very few respondents use it for all cases of Postpartum Haemorrhage (16.4%; p<0.001). Barriers against its use include non-awareness of the latest WHO recommendation, preference for other utero-tonics and cost of the drug.
Conclusions There was poor knowledge of Tranexamic acid, poor awareness of its recommendation and low use for Postpartum Haemorrhage among different cadres of health care providers.
Synopsis There was poor knowledge of Tranexamic acid, poor awareness of its recommendation and low use for Postpartum Haemorrhage among different cadres of health care providers.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical clearance was obtained from the ethical committee of the University of Nigeria Teaching Hospital
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
